Stay updated with breaking news from Co Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx,"), a molecular diagnostics company with a unique, patented platform for the...
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 1,900,000 shares, a growth of 24.2% from the March 15th total of 1,530,000 shares. Based on an average trading volume of 451,800 shares, the short-interest ratio is presently […]